# Vision Improvement for Legally Blind Dry AMD Patients

> **NCT04875234** · — · NOT_YET_RECRUITING · sponsor: **Optimal Acuity Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Dry Age-related Macular Degeneration
- Vision Impairment and Blindness

## Interventions

- **DEVICE:** Clear-K Low Vision Aid Treatment

## Key facts

- **NCT ID:** NCT04875234
- **Lead sponsor:** Optimal Acuity Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01
- **Primary completion:** 2025-07
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04875234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04875234, "Vision Improvement for Legally Blind Dry AMD Patients". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04875234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*